
Keywords: بیفیدوباکتریوم breve; Gut microbiota; Inflammatory bowel disease; Metagenomics; Probiotics; Fecal microbiota transplantation; Therapy; ATG16L1; autophagy-related protein 16L1; Bacteroides ovatus; B. ovatus; Bifidobacterium breve; B. breve; Bifidobacterium longum; B. longum; CD